⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
BEAM News
Beam Therapeutics Inc. Common Stock
Sickle Cell Care Reaches an Inflection Point as Gene Therapy Enthusiasm Rises, but Referral Pathways and Uptake Lag Amid Due to Treatment Burden
globenewswire.com
NVO
AGIO
BEAM
EDIT
SNY
PFE
MAKER'S MARK UNVEILS 2026 WOOD FINISHING SERIES: THE STEWARDS RELEASE
prnewswire.com
BEAM
Form 8-K
sec.gov
BEAM
Protego Biopharma Appoints John M. Maraganore, Ph.D., to Board of Directors
prnewswire.com
ALNY
BIIB
BEAM
Form 8-K
sec.gov
BEAM
Beam Therapeutics Reports Fourth Quarter and Year-End 2025 Financial Results and Announces New Liver-Targeted Genetic Disease Program in Phenylketonuria (PKU)
globenewswire.com
BEAM
Beam Therapeutics Announces $500 Million Strategic Financing Facility with Sixth Street
globenewswire.com
BEAM
Beam Therapeutics to Host Investor Webcast for Fourth Quarter and Year-End 2025 Financial Results and New Liver-targeted Genetic Disease Program
globenewswire.com
BEAM
EXPERT MIXOLOGY MEETS HERITAGE BOURBON IN NEW ON THE ROCKS™ WHISKEY SOUR CRAFTED WITH JIM BEAM® KENTUCKY STRAIGHT BOURBON
prnewswire.com
BEAM
Growth Factors Market to Reach US$ 3.7 Bn by 2033, Expands Amid Rising Regenerative Medicine and Biopharmaceutical Innovation - Persistence Market Research
prnewswire.com
TMO
MRK
BIO
BIIB
AMGN
GILD
REGN
CRSP
NTLA
BMY
ABBV
AZN
NVS
PFE
JNJ
MRNA
BNTX
COR
STEM
ALGN
EXAS
MDLZ
BHC
CVS
UNH
CI
CNC
ELAN
ZTS
ISRG
QRVO
SWKS
AVGO
QCOM
INTC
MSFT
GOOG
AMZN
IBM
ORCL
CRM
ADBE
NFLX
DIS
MCD
SBUX
KO
PEP
PG
JPM
BAC
WFC
C
GS
MS
AXP
V
MA
HD
LOW
COST
TGT
WMT
BBY
CMCSA
VZ
T
XOM
CVX
SIRI
UBER
LYFT
NVDA
AMD
MU
AMAT
LRCX
ASML
ADI
TXN
QGEN
ILMN
VRTX
EDIT
BEAM
SRPT
ACAD
ALKS
MDT
SYK
DHR
GOOGL